Moreover, participants with a family history of BRCA1/2 cancers presented higher levels of self-efficacy (M = 3.89, DS = 0.77, t(123) = -2.028, p = .05) than participants with no family history (M = 3.57, DS = 0.83). The gene discussed is BRCA1; the disease is cancer.